What Does AMP Mean on a Drug Test? (Amphetamines)?
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026
Quick answer: AMP is the laboratory abbreviation for Amphetamines. AMP is the amphetamine strip — it flags mixed amphetamine salts-class prescriptions AND street speed alike. Prescription verified through the MRO reports negative.
Reading your cup or lab report
Multi-panel cups print 2–4 letter codes beside each strip line. One line per drug class; a visible control line plus absent drug line = negative for that class. Faint lines still count as present (they're competitive-inhibition assays) — the classic misread.
About Amphetamines
Urine: 500 ng/mL initial screen; GC–MS confirm at 250 ng/mL requiring d-amphetamine (methamphetamine confirm additionally requires methamphetamine ≥250 ng/mL).
Amphetamines are on every standard panel including the federal 5-panel. A prescription does not exempt you — it explains the result. Take your prescription (or pharmacy printout) to the collection site or have it ready for the Medical Review Officer call; verified prescriptions are reported as negative.
Detection windows
| Test type | Typical Amphetamines detection window |
|---|---|
| Urine | occasional: 1–3 days · regular: up to 4–5 days |
| Saliva (Mouth Swab) | any: 1–2 days (20–50 hours) |
| Hair Follicles | up to 90 days |
| Blood | any: ~12–24 hours |
Related codes on the same cup
Cups group codes logically: AMP/mAMP (stimulants), OPI/MOP/OXY/BUP (opioid family), BZO/BAR (depressants), COC/THC/PCP (classics), plus validity markers like creatinine printed on lab reports rather than cups.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)